Celltrion's FDA approval of Steqeyma enhances pediatric psoriasis treatment, offering flexible dosing options for children ...

If you feel your psoriasis treatment is not producing what you seek here are 10 key factors that might be hindering your ...

Doctors explain how conditions like psoriasis, type 1 diabetes, and inflammatory bowel disease impact men, plus how these ...

ABOUT 5.7 MILLION men could have an autoimmune disease, according to a 2024 study published in the Journal of Clinical ...

To evaluate this, the authors systematically reviewed 14 studies involving a total of 169 patients (mean age 46.8 years), 74% ...

"The BIO International Convention provides an ideal platform to showcase how FibroBiologics is potentially transforming the treatment landscape for chronic diseases,” said Pete O'Heeron. "With our ...

Celltrion, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved a new presentation of STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), in a ...

Icotrokinra was safe and effective for improving skin clearance among patients with at least moderate psoriasis in ...

Additionally, some infections may exacerbate or trigger psoriasis, such as strep throat. Regardless of whether you are on a biologic or immunosuppressive medication for psoriasis, it’s essential ...

Patients with low psoriasis body surface area (BSA) can have similar quality of life impacts and symptom burdens as those ...

The FamilyPso questionnaire revealed caregiver burden among partners and family members of patients with psoriasis, which ...

Chronic cough (CC) is common, predominantly affecting middle-aged females. Sufferers experience significantly impaired quality of life (QoL). Cough is associated with increased healthcare costs.